ResApp’s contracted Clinical Research Organisation and the site Principal Investigators have notified the Company that adjudication is progressing well and that based on the projected availability of adjudicators it will be approximately two weeks before the data is un-blinded and preliminary top-line results are delivered.
- Forums
- ASX - By Stock
- RAP
- Ann: ResApp Provides Update on SMARTCOUGH-C-2 Study Timing
Ann: ResApp Provides Update on SMARTCOUGH-C-2 Study Timing, page-2
-
-
- There are more pages in this discussion • 174 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
Previous Video
Next Video
SPONSORED BY The Market Online